Answers are grounded in this paper and cite their sources.
An alpha-glucosidehydrolase inhibitor (acarbose; BAY g 5421) taken with food was compared with dummy tablets in seven insulin-treated diabetic patients over eight-hour periods that included breakfast, lunch, and two snacks. Acarbose diminished the postprandial increases in blood glucose, lactate, and pyruvate concentrations and may therefore be of value in the management of insulin-dependent diabetes.
No takes yet. Share an insight, caveat, or question.
Walton et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: